CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology

Friday, November 9, 2018 1 min read

Key Takeaway: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology

Full Press Release Details

CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology.